Zobrazeno 1 - 10
of 460
pro vyhledávání: '"Susantitaphong P"'
Autor:
Takkavatakarn K, Phannajit J, Udomkarnjananun S, Tangchitthavorngul S, Chariyavilaskul P, Sitticharoenchai P, Praditpornsilpa K, Eiam-Ong S, Susantitaphong P
Publikováno v:
International Journal of Nephrology and Renovascular Disease, Vol Volume 15, Pp 115-126 (2022)
Kullaya Takkavatakarn,1 Jeerath Phannajit,1 Suwasin Udomkarnjananun,1 Suri Tangchitthavorngul,1 Pajaree Chariyavilaskul,2,3 Patita Sitticharoenchai,4 Kearkiat Praditpornsilpa,1 Somchai Eiam-Ong,1 Paweena Susantitaphong1,5 1Division of Nephrology, Dep
Externí odkaz:
https://doaj.org/article/1a429f2d6f4448e093689eb7d8d4ae94
Autor:
Viyada Sanoesan, Jeerath Phannajit, Kanaungnit Kingpetch, Thunyaluk Sawatnatee, Benchamat Phromphao, Paweena Susantitaphong, Chanan Sukprakun, Kitiwat Khamwan
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract This study investigated whether Ki–Patlak derived from a shortened scan time for dynamic 18F-NaF PET/CT in chronic kidney disease (CKD) patients undergoing hemodialysis can provide predictive accuracy comparable to that obtained from a lon
Externí odkaz:
https://doaj.org/article/75c2921d28d3427eb1761902da6954ed
Autor:
Pajaree Chariyavilaskul, Nantaporn Prompila, Supeecha Wittayalertpanya, Sookruethai Lekhyananda, Wisit Prasithsirikul, Thananda Trakarnvanich, Somboon Jeenapongsa, Paweena Susantitaphong, Stephen Kerr, Anchalee Avihingsanon, Pisit Tangkijvanich, Kearkiat Praditpornsilpa
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 7, Pp n/a-n/a (2024)
Abstract Sofosbuvir/Velpatasvir (SOF/VEL) is a combination drug used for chronic hepatitis C (HCV) infection. However, limited information exists regarding the pharmacokinetics of SOF/VEL and its metabolites in hemodialysis patients. We conducted a p
Externí odkaz:
https://doaj.org/article/9c0b2bc296e342e2868e2e22521a2dbf
Autor:
Wannasit Wathanavasin, Athiphat Banjongjit, Jeerath Phannajit, Somchai Eiam-Ong, Paweena Susantitaphong
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-15 (2024)
Abstract Several studies have reported an increased risk of chronic kidney disease (CKD) outcomes after long-term exposure (more than 1 year) to particulate matter with an aerodynamic diameter of ≤ 2.5 µm (PM2.5). However, the conclusions remain i
Externí odkaz:
https://doaj.org/article/1794e14242da4210824f73dc40e83fc5
Autor:
Naruchorn Kijpaisalratana, Chanon Ariyaprakai, Kitiporn Sriamornrattanakul, Somkiat Wongsuriyanan, Nasaeng Akharathammachote, Paweena Susantitaphong, Nijasri C. Suwanwela
Publikováno v:
Cerebrovascular Diseases Extra, Pp 1-1 (2024)
Background: Moyamoya disease (MMD) is an uncommon cause of stroke. Antiplatelet treatment is commonly prescribed for patients with MMD despite the lack of strong evidence supporting its efficacy. We conducted a systematic review to evaluate evidence
Externí odkaz:
https://doaj.org/article/9a632f41fefc4923b2b0294db0315f68
Autor:
Dhawinee Kritsernvong, Sutira Uaamnuichai, Rada Poolkumlung, Lalita Wattanachanya, Paweena Susantitaphong, Jiayu Li, Sukanya Chaikittisilpa, Somsook Santibenchakul, Unnop Jaisamrarn
Publikováno v:
Osteoporosis and Sarcopenia, Vol 9, Iss 4, Pp S12- (2023)
Externí odkaz:
https://doaj.org/article/64d799df2b0b4d54b6860d6345702f60
Autor:
Narisorn Lakananurak, Panyavee Pitisuttithum, Paweena Susantitaphong, Tanisa Patcharatrakul, Sutep Gonlachanvit
Publikováno v:
Nutrients, Vol 16, Iss 3, p 464 (2024)
Background: International guidelines recommend dietary interventions as one of the most important treatments for patients with gastroesophageal reflux disease (GERD). Evidence to confirm the efficacy of these treatment modalities is lacking. The pres
Externí odkaz:
https://doaj.org/article/9169b004ac514b2299ffe86b24b8a300
Autor:
Montira Assanatham, Oraluck Pattanaprateep, Anan Chuasuwan, Kriengsak Vareesangthip, Ouppatham Supasyndh, Adisorn Lumpaopong, Paweena Susantitaphong, Chutatip Limkunakul, Wanchana Ponthongmak, Kamolpat Chaiyakittisopon, Ammarin Thakkinstian, Atiporn Ingsathit
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background This study aimed to conduct a cost-utility analysis of the “Peritoneal Dialysis (PD)-First” policy in 2008 under a universal health coverage scheme and hemodialysis (HD) in Thai patients with End-stage Kidney Disease (ESKD) us
Externí odkaz:
https://doaj.org/article/d698d11e12594d5796da6e580902b24e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.